Immutep partners with LabCorp to develop immotherapy diagnostic

Sydney biotech Immutep has partnered with S&P500 stock LabCorp to develop a diagnostic test helping doctors and oncologists. … Read More

The post Immutep partners with LabCorp to develop immotherapy diagnostic appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *